20.02.2015 MediClin AG  DE0006595101

DGAP-News: MediClin AG: Group sales increased by EUR 23.1 mill. up to EUR 538.0 mill.; preliminary Group operating result amounts to EUR 15.6 mill.


 
DGAP-News: MediClin AG / Key word(s): Preliminary Results MediClin AG: Group sales increased by EUR 23.1 mill. up to EUR 538.0 mill.; preliminary Group operating result amounts to EUR 15.6 mill. 20.02.2015 / 14:00 --------------------------------------------------------------------- Group sales increased by EUR 23.1 mill. up to EUR 538.0 mill.; preliminary Group operating result amounts to EUR 15.6 mill. Offenburg, February 20, 2015 - MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 538.0 mill. in the 2014 FY. The sales plus was EUR 23.1 mill. or 4.5 % against previous year. The largest share of sales growth - about eighty percent - accounted for the post-acute segment, which had not to face the usual seasonal slowdown of occupancy in the 1st. and 4th quarter 2014. The occupancy rate of the Group rose from 84.7 % to 87.3 %. The number of cases increased 1.8 % to almost 121 thousand cases. The preliminary Group operating result (Group-EBIT) increased from EUR 2.2 mill. to EUR 15.6 mill. and the preliminary result attributable to shareholders from EUR -2.6 mill. to EUR 8.5 mill. Earnings per share account to EUR 0.18 (previous year: EUR -0.06). EUR 21.0 mill (previous year: EUR 18.6 mill.) were invested in capital expenditure in the 2014 FY including EUR 5.2 mill. (previous year: EUR 4.4 mill.) subsidies. As of December 31, 2014 cash and cash equivalents amount to EUR 26.3 mill. (31.12.2013: EUR 13.2 mill.); the equity ratio is 48.2 %. The press conference and the analysts and investor conference will take place in Frankfurt on March 19, 2015. From that date onwards the annual report 2014 will be available under www.mediclin.de. About MediClin AG (Ticker: MED; WKN: 659 510) MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins' facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees. --------------------------------------------------------------------- 20.02.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MediClin AG Okenstraße 27 77652 Offenburg Germany Phone: +49 (0)781 488-189 Fax: +49 (0)781 488-184 E-mail: [email protected] Internet: www.mediclin.de ISIN: DE0006595101 WKN: 659510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 325563 20.02.2015


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 609,08 645,11 673,09 659,86 673,14 704,70 730,07
EBITDA1,2 27,01 37,35 93,58 77,50 85,22 90,92 98,73
EBITDA-Marge3 4,43 5,79 13,90 11,74 12,66 12,90
EBIT1,4 6,62 15,06 22,41 0,15 11,56 19,52 12,72
EBIT-Marge5 1,09 2,33 3,33 0,02 1,72 2,77 1,74
Jahresüberschuss1 3,96 7,76 9,68 -0,04 1,49 9,72 -10,72
Netto-Marge6 0,65 1,20 1,44 -0,01 0,22 1,38 -1,47
Cashflow1,7 19,34 29,77 69,59 118,69 81,97 34,64 78,00
Ergebnis je Aktie8 0,08 0,16 0,20 -0,19 0,03 0,20 -0,23
Dividende8 0,05 0,05 0,05 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Mediclin
WKN Kurs in € Einschätzung Börsenwert in Mio. €
659510 2,700 Halten 128,25
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
10,38 19,24 0,53 20,30
KBV KCV KUV EV/EBITDA
0,65 1,64 0,18 1,50
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,00 0,00 0,00 06.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
02.05.2024 31.07.2024 04.11.2024 26.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
4,98% -0,92% -1,46% -11,76%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu MediClin AG  ISIN: DE0006595101 können Sie bei EQS abrufen


Pflegeeinrichtungen , 659510 , MED , XETR:MED